|
Name |
Amestolkolide B
|
| Molecular Formula | C24H26O8 | |
| IUPAC Name* |
(1R,2S,11R,12R,14R,17R,19R,21S)-2,6,6,14,19-pentamethylspiro[7,16,18-trioxapentacyclo[12.6.1.02,12.05,10.017,21]henicosa-4,9-diene-11,2'-oxirane]-3,8,15,20-tetrone
|
|
| SMILES |
C[C@@H]1C(=O)[C@@H]2[C@@H]3[C@H](O1)OC(=O)[C@@]3(C[C@@H]4[C@@]2(C(=O)C=C5C(=CC(=O)OC5(C)C)[C@@]46CO6)C)C
|
|
| InChI |
InChI=1S/C24H26O8/c1-10-18(27)16-17-19(30-10)31-20(28)22(17,4)8-13-23(16,5)14(25)6-11-12(24(13)9-29-24)7-15(26)32-21(11,2)3/h6-7,10,13,16-17,19H,8-9H2,1-5H3/t10-,13-,16+,17-,19-,22-,23-,24+/m1/s1
|
|
| InChIKey |
PCBBMDQLBUYDDZ-NBYUEMIISA-N
|
|
| Synonyms |
Amestolkolide B
|
|
| CAS | NA | |
| PubChem CID | 71550882 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 442.5 | ALogp: | 0.2 |
| HBD: | 0 | HBA: | 8 |
| Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 109.0 | Aromatic Rings: | 6 |
| Heavy Atoms: | 32 | QED Weighted: | 0.415 |
| Caco-2 Permeability: | -5.272 | MDCK Permeability: | 0.00001810 |
| Pgp-inhibitor: | 0.999 | Pgp-substrate: | 0.004 |
| Human Intestinal Absorption (HIA): | 0.012 | 20% Bioavailability (F20%): | 0.871 |
| 30% Bioavailability (F30%): | 0.315 |
| Blood-Brain-Barrier Penetration (BBB): | 0.973 | Plasma Protein Binding (PPB): | 84.88% |
| Volume Distribution (VD): | 2.357 | Fu: | 17.63% |
| CYP1A2-inhibitor: | 0.016 | CYP1A2-substrate: | 0.927 |
| CYP2C19-inhibitor: | 0.328 | CYP2C19-substrate: | 0.778 |
| CYP2C9-inhibitor: | 0.169 | CYP2C9-substrate: | 0.021 |
| CYP2D6-inhibitor: | 0.009 | CYP2D6-substrate: | 0.082 |
| CYP3A4-inhibitor: | 0.272 | CYP3A4-substrate: | 0.56 |
| Clearance (CL): | 4.191 | Half-life (T1/2): | 0.628 |
| hERG Blockers: | 0.027 | Human Hepatotoxicity (H-HT): | 0.104 |
| Drug-inuced Liver Injury (DILI): | 0.551 | AMES Toxicity: | 0.751 |
| Rat Oral Acute Toxicity: | 0.597 | Maximum Recommended Daily Dose: | 0.677 |
| Skin Sensitization: | 0.577 | Carcinogencity: | 0.79 |
| Eye Corrosion: | 0.071 | Eye Irritation: | 0.013 |
| Respiratory Toxicity: | 0.703 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005628 | ![]() |
0.794 | D0KR9U | ![]() |
0.232 | ||
| ENC004709 | ![]() |
0.623 | D02JNM | ![]() |
0.226 | ||
| ENC003925 | ![]() |
0.579 | D0D2TN | ![]() |
0.223 | ||
| ENC003927 | ![]() |
0.550 | D0Y2YP | ![]() |
0.223 | ||
| ENC003926 | ![]() |
0.541 | D03ZZK | ![]() |
0.216 | ||
| ENC003843 | ![]() |
0.531 | D0Q4SD | ![]() |
0.214 | ||
| ENC005627 | ![]() |
0.455 | D02QJH | ![]() |
0.211 | ||
| ENC002851 | ![]() |
0.318 | D09WYX | ![]() |
0.208 | ||
| ENC002987 | ![]() |
0.291 | D0K7LU | ![]() |
0.205 | ||
| ENC000924 | ![]() |
0.289 | D0I5DS | ![]() |
0.205 | ||